Iphigenia L. Koumenis

Safety and antitumor activity of recombinant soluble Apo2 ligand

Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text

Apo2l Mrna, Medicinal Chemistry, Apo2l Treatment +13

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes

Marios C. Papadopoulos, Iphigenia L. Koumenis, Laura L. Dugan et al. · Brain Research · 1997 · 105 citations

Metabolic Syndrome, Deprivation Injury Correlates, Physiology +11

Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses

Marios C. Papadopoulos, Iphigenia L. Koumenis, Tien‐Min Yuan et al. · Neuroscience · 1997 · 69 citations

Potentiation of murine astrocyte antioxidant defence by bcl‐2: protection in part reflects elevated glutathione levels

Marios C. Papadopoulos, Iphigenia L. Koumenis, Lijun Xu et al. · European Journal of Neuroscience · 1998 · 65 citations